LIVRALIB
Live / Registered — Registered — Section 71 accepted (as of 27 Feb 2025)
What this means for you
Registered since 15 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79204654
- Registration number
- 5263114
- Mark type
- Stylized text
- Filed
- 18 Dec 2016
- Published for opposition
- 30 May 2017
- Registered
- 15 Aug 2017
- Attorney of record
- Jason M. Vogel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment and prevention of liver diseases, cancer, hepatitis, and non-alcoholic fatty liver syndrome
Owner
- Can-Fite Biopharma Ltd, Petah Tikva, IL
- Can-Fite Biopharma Ltd, Petah Tikva, IL
- Can-Fite Biopharma Ltd, Petah Tikva, IL
Prosecution history
- 27 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 27 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 01 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 20 Aug 2024 — POST REGISTRATION ACTION MAILED - SEC.71
- 16 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Aug 2023 — TEAS SECTION 71 RECEIVED
- 06 Feb 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Feb 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Oct 2017 — NOTIFICATION PROCESSED BY IB
- 21 Sept 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Sept 2017 — FINAL DISPOSITION PROCESSED
- 14 Sept 2017 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 15 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 30 May 2017 — PUBLISHED FOR OPPOSITION
- 10 May 2017 — NOTICE OF PUBLICATION